ABOUT US

The UCL Cancer Institute is the hub for cancer research at University College London, one of the World’s leading universities. The Institute draws together over 400 talented scientists who are working together to translate research discoveries into developing kinder, more effective therapies for cancer patients. In particular, it fosters links between basic cancer researchers across biomedicine and with the clinical activities of our four partner hospital trusts, known as UCL Partners (University College London Hospital NHS Foundation Trust, Great Ormond Street Hospital for Children NHS Trust, the Royal Free Hampstead NHS Trust, and Moorfields Eye Hospital NHS Foundation Trust), as well as the London School of Pharmacy and Cancer Research UK. The Institute has greater clinical links than any comparable centre in the UK, creating a unique opportunity for significant impact on the delivery of clinical service to cancer patients. The Cancer Institute includes the Cancer Research UK and UCL Cancer Trials Centre which is one of the largest cancer trials centres in the UK conducting multi-centre national and international phase III trials, feasibility studies and early phase I and II studies. Also embedded within the UCL Cancer Institute is the CRUK City of London Centre, a world class hub for cancer biotherapeutics which fosters collaboration between researchers at University College London, King’s College London, Barts Cancer Institute (Queen Mary University of London), and The Francis Crick Institute. Furthermore, the Institute offers educational programmes that reflect the depth and breadth of research expertise that include BSc Cancer Biomedicine, MSci Cancer Biomedicine, iBSc Oncology, MSc Cancer and PhD studies. Further Information about the UCL Cancer Institute can be found on our website https://www.ucl.ac.uk/cancer/.

THIS IS A FULL-TIME POSITION FUNDED FOR 1 YEAR IN THE FIRST INSTANCE, SUBJECT TO STANDARD PROBATIONARY REQUIREMENTS, WITH THE POSSIBILITY OF EXTENSION.

Applications should include a CV and a Cover Letter: In the Cover Letter please provide evidence of the essential and desirable criteria in the Person Specification part of the Job Description. (By including a Cover Letter, you can leave blank the ‘Why you have applied for this role’ field in the application form, which is limited in the number of characters it will allow.)

ABOUT THE ROLE

The major focus of the UCL Translation team is the manipulation of T-cells for therapeutic application. The UCL CAR T-cell programme is the most comprehensive in Europe, encompassing a broad-ranging portfolio of studies actively recruiting patients with B and T-cell malignancies, myeloma, neuroblastoma, and gliomas.
The postholder will form part of the CAR T-cell manufacturing team, at the Centre for Cell, Gene and Tissue Therapeutics and supports the delivery of cell therapy products, being responsible for the quality control of cell therapeutical products and carrying out process development activities for the introduction of new trials.
This is a unique opportunity to join a leading academic team at the forefront of CAR-T cells clinical research and contribute to cutting-edge research to improve the delivery of better products to patients.

As well as the exciting opportunities this role presents we also offer some great benefits some of which are below:

• 41 Days holiday (including 27 days annual leave 8 bank holiday and 6 closure days)
• Defined benefit career average revalued earnings pension scheme (CARE)
• Cycle to work scheme and season ticket loan
• On-Site nursery
• On-site gym
• Enhanced maternity, paternity and adoption pay
• Employee assistance programme: Staff Support Service
• Discounted medical insuranc